Open AccessIncidence, Risk Factors, and Management of Infusion‐Related Reactions in Breast Cancer Patients Receiving Trastuzumab
Author(s) -
Thompson Lisa M.,
Eckmann Karen,
Boster Bonnie L.,
Hess Kenneth R.,
Michaud Laura B.,
Esteva Francisco J.,
Hortobágyi Gabriel N.,
Barnett Chad M.
Publication year - 2014
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2013-0286
Subject(s) - trastuzumab , medicine , incidence (geometry) , breast cancer , oncology , population , cancer , logistic regression , physics , environmental health , optics
Learning ObjectivesIdentify risk factors associated with trastuzumab‐associated infusion‐related reactions. Describe the impact of premedications on the incidence and/or severity of trastuzumab‐associated infusion‐related reactions.